PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. MRNA
10. KNX

Go back to PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results

PTC Therapeutics (PTCT) Misses Q1 EPS by 32c, Revenues Beat

May 4, 2021 5:31 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.83), $0.32 worse than the analyst estimate of ($1.51). Revenue for the quarter came in at $117.94 million versus the consensus estimate of $98.8 million.

First Quarter 2021 Financial Highlights:

Total revenues were $117.9 million for the first quarter of 2021, compared to total revenues of $68.3 million for the first quarter of 2020, a 32% increase. Total revenue includes net product revenue of $91.3 million and collaboration and royalty revenue of $26.7 million in the first quarter of 2021.Translarna net product revenues were $46.5 million for the first quarter of 2021, compared to $40.5 million... More